Treatment of pregnancy loss in Hughes syndrome: A critical update

Autoimmunity Reviews

Volumn 1, Issue 5, 2002, Pages 298-304

  Ruiz Irastorza, Guillermo ^a,b   Khamashta, Munther A ^a   Hughes, Graham R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b HOSPITAL DE CRUCES   (Spain)

Author keywords

Antiphospholid; Aspirin; Corticosteroids; Heparin; Immunoglobulins; Obstetric

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; HEPARIN; IMMUNOGLOBULIN; PHOSPHOLIPID ANTIBODY; PREDNISONE; STEROID;

ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; FEMALE; FETUS DEATH; GENETIC HETEROGENEITY; HUMAN; PREGNANCY; RECURRENT DISEASE; SAMPLING; SPONTANEOUS ABORTION; CLINICAL TRIAL; RECURRENT ABORTION; REVIEW;

ABORTION, HABITUAL; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; CLINICAL TRIALS; FEMALE; HEPARIN; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PREDNISONE; PREGNANCY;

EID: 0038754474     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(02)00067-8     Document Type: Review

References (34)

1. Gharavi A.E., Pierangeli S.S., Levy R.A., Harris E.N. Mechanisms of pregnancy loss in antiphospholipid syndrome. Clin Obstet Gynecol. 44:2001;11-19.
2. Kupferminc M.J., Eldor A., Steinman N., et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 340:1999;9-13.
3. Stone S., Khamashta M.A., Poston L. Placentation, antiphospholipid syndrome and pregnancy outcome. Lupus. 10:2001;67-74.
4. Porter T.F., Silver R.M., Branch D.W. Pregnancy loss and antiphospholipid antibodies. Khamashta M.A. Hughes syndrome. 2000;179-194 Springer, London.
5. Loizou S., Byron M.A., Englert H.J., David J., Hughes G.R.V., Walport M.J. Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. QJ Med. 255:1988;525-531.
6. Oshiro B.T., Silver R.M., Scott J.R., Yu H., Branch D.W. Antiphospholipid antibodies and fetal death. Obstet Gynecol. 87:1996;489-493.
7. Silver R.M., Porter T.F., van Leeuween I., Jeng G., Scott J.R., Branch D.W. Anticardiolipin antibodies: clinical consequences of 'low titers'. Obstet Gynecol. 87:1996;494-500.
8. Wilson W.A., Gharavi A.E., Koike T., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum. 42:1999;1309-1311.
9. Welsch S., Branch D.W. Antiphospholipid syndrome in pregnancy: obstetric concerns and treatment. Rheum Dis Clin North Am. 23:1997;71-84.
10. Lima F., Khamashta M.A., Buchanan N.M.M., Kerslake S., Hunt B.J., Hughes G.R.V. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol. 14:1996;131-136.
11. Lockshin M.D., Druzin M.I., Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol. 160:1989;439-443.
12. Ramsey-Goldman R., Kutzer J.E., Kuller L.H., Guzick D., Carpenter A.B., Medsger T.A. Pregnancy outcome and anti-cardiolipin antibody in women with systemic lupus erythematosus. Am J Epidemiol. 138:1993;1057-1069.
13. Out H.J., Bruinse H.W., Christiaens G.C.M.L., et al. A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol. 167:1992;26-32.
14. Cowchock S., Reece A. Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Am J Obstet Gynecol. 176:1997;1099-1100.
15. Lynch A., Silver R., Emlen W. Antiphospholipid antibodies in healthy pregnant women. Rheum Dis Clin North Am. 23:1997;55-70.
16. Geis W., Branch D.W. Obstetric implications of antiphospholipid antibodies: pregnancy loss and other complications. Clin Obstet Gynecol. 44:2001;2-10.
17. Empson M., Lassere M., Craig J.C., Scott J.R. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol. 99:2002;135-144.
18. Branch D.W., Scott J.R., Kochenour N.K., Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med. 313:1985;1322-1326.
19. Silveira L.H., Hubble C.L., Jara L.J., Saway S., Martinez-Osuna P., Sekznick M.J., Angel J., O'Brien W., Espinoza L.R. Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin. Am J Med. 93:1992;403-411.
20. Cowchock F.S., Reece E.A., Balaban D., Branch D.W., Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomised trial comparing prednisone with low-dose heparin. Am J Obstet Gynecol. 166:1992;1318-1323.
21. Silver R.K., MacGregor S.N., Sholl J.S., Hobart J.M., Neerhof M.G., Ragin A. Comparative trial of prednisone plus aspirin vs. aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol. 169:1993;1411-1417.
22. Laskin C.A., Bombardier C., Hannah M.E., et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med. 337:1997;148-153.
23. Branch D.W., Silver R.M., Blackwell J.L., Reading J.C., Scott J.R. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol. 80:1992;614-620.
24. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 174:1996;1584-1589.
25. Kutteh W.H., Ermel L.D. A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol. 35:1996;402-407.
26. Rai R., Cohen H., Dave M., Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J. 314:1997;253-257.
27. Granger K.A., Farquharson R.G. Obstetric outcome in antiphospholipid syndrome. Lupus. 6:1997;509-513.
28. Farquharson R.G., Quenby S., Greaves M. Antiphospholipid syndrome in pregnancy: a controlled treatment trial (abstract). J Obstet Gynaecol. 21: (suppl 1):2001;S22.
29. Pattison N.S., Chamley L.W., Birdsall M., Zanderigo A.M., Liddel H.S., McDougall J. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomised controlled trial. Am J Obstet Gynecol. 183:2000;1008-1012.
30. Ruiz-Irastorza G., Nelson-Piercy C., Khamashta M.A. Aspirin to treat obstetric manifestations of the antiphospholipid syndrome (letter). Am J Obstet Gynecol. 185:2001;523-524.
31. Ruiz-Irastorza G., Khamashta M., Hughes G. Treatment of the antiphospholipid syndrome in pregnancy. Scand J Rheumatol. 27:(suppl 107):1998;44-47.
32. Branch D.W., Peaceman A.M., Druzin M., et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. Am J Obstet Gynecol. 182:2000;122-127.
33. Backos M., Rai R., Baxter N., Chilcott I.T., Cohen H., Regan L. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol. 106:1999;102-107.
34. Ruiz-Irastorza G., Khamashta M.A., Hughes G.R.V. Systemic lupus erythematosus and antiphospholipid syndrome during pregnancy: maternal and fetal complications and their management. IMAJ. 2:2000;462-469.